Company intelligence / Profile preview

BnH Research

Goyang-si, Gyeonggi-do, South Koreabnhresearch.net ↗

Ownership: Private
Development stage: Preclinical

Overview

BnH Research is a South Korea-based biopharmaceutical company focused on developing therapeutics for chronic conditions, particularly central nervous system (CNS) disorders. Its lead programs are in preclinical stages, with at least one candidate targeting autism spectrum disorder and another as an hdac6 inhibitor for CNS diseases such as Alzheimer's disease. The company has recently secured significant Series B funding to advance its pipeline

Therapeutic areas: PsychiatryOphthalmologyNeurology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

4 assets

BnH-015B

3 more assets in the full pipeline.

Request access →

Partnerships

CMC agreement with Wuxi, China (manufacturing partner)GLP agreement with LSSI, Japan (preclinical/GLP services)

Beyond the preview

Go deeper on BnH Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BnH Research.

Explore the full profile